Unknown

Dataset Information

0

Antidepressant sertraline increases thioflavin-S and Congo red deposition in APPswe/PSEN1dE9 transgenic mice.


ABSTRACT: Introduction: Depression is strongly associated with Alzheimer's disease (AD). Antidepressants are commonly used in patients before and after their diagnosis of AD. To date, the relationship between antidepressants and AD remains unclear. Methods: In our study, we administered sertraline or paroxetine to wild type (WT) and APPswe/PSEN1dE9 (APP/PSEN1) transgenic mouse models for up to 12 months. We quantified the drug concentrations using LC-MS/MS analysis and measured serum serotonin level using an ELISA assay. Additionally, we evaluated the amyloid burdens through thioflavin-S and Congo red stainings, and recognition memory using the novel object recognition test. Results: Our findings revealed that mice treated with paroxetine exhibited a significantly higher level of weight gain compared to the control group and increased mortality in APP/PSEN1 mice. After 12 months of antidepressant treatment, the sertraline level was measured at 289.8 ng/g for cerebellum, while the paroxetine level was 792.9 ng/g for cerebellum. Sertraline significantly increased thioflavin-S and Congo red depositions, along with gliosis, in both isocortex and hippocampus of APP/PSEN1 mice compared to the control group. Both antidepressants also led to a decreased recognition index in APP/PSEN1 mice. Conclusion: These findings suggest a potential role of sertraline in AD pathogenesis, emphasizing the need to reassess the use of these antidepressants in patients with AD.

SUBMITTER: Liao MH 

PROVIDER: S-EPMC10800414 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature

altmetric image

Publications

Antidepressant sertraline increases thioflavin-S and Congo red deposition in APPswe/PSEN1dE9 transgenic mice.

Liao Ming-Hsuan MH   Lin Yen-Kuang YK   Gau Fong-Ying FY   Tseng Chun-Che CC   Wu Da-Chih DC   Hsu Chu-Yuan CY   Chung Kuo-Hsuan KH   Li Rung-Chi RC   Hu Chaur-Jong CJ   Then Chee Kin CK   Shen Shing-Chuan SC  

Frontiers in pharmacology 20240108


<b>Introduction:</b> Depression is strongly associated with Alzheimer's disease (AD). Antidepressants are commonly used in patients before and after their diagnosis of AD. To date, the relationship between antidepressants and AD remains unclear. <b>Methods:</b> In our study, we administered sertraline or paroxetine to wild type (WT) and APPswe/PSEN1dE9 (APP/PSEN1) transgenic mouse models for up to 12 months. We quantified the drug concentrations using LC-MS/MS analysis and measured serum seroton  ...[more]

Similar Datasets

| S-EPMC5502748 | biostudies-literature
| S-EPMC9033779 | biostudies-literature
| S-EPMC6369353 | biostudies-literature
| S-EPMC9599050 | biostudies-literature
| S-EPMC5736306 | biostudies-literature
| S-EPMC4424277 | biostudies-literature
| S-EPMC5742922 | biostudies-literature
| S-EPMC2278120 | biostudies-literature
| S-EPMC8155296 | biostudies-literature
| S-EPMC8450872 | biostudies-literature